|
C4ORF41 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.175500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.664800E-03 |
| Normal-vs-Stage2 |
6.908600E-01 |
| Normal-vs-Stage3 |
3.258400E-02 |
| Normal-vs-Stage4 |
1.002440E-01 |
| Stage1-vs-Stage2 |
2.489800E-01 |
| Stage1-vs-Stage3 |
6.981200E-01 |
| Stage1-vs-Stage4 |
6.185000E-01 |
| Stage2-vs-Stage3 |
2.075200E-01 |
| Stage2-vs-Stage4 |
2.329400E-01 |
| Stage3-vs-Stage4 |
8.189200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.982800E-03 |
| Normal-vs-AfricanAmerican |
8.036200E-02 |
| Normal-vs-Asian |
2.995700E-02 |
| Caucasian-vs-AfricanAmerican |
9.052200E-01 |
| Caucasian-vs-Asian |
5.045400E-01 |
| AfricanAmerican-vs-Asian |
5.113000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.784800E-04 |
| Normal-vs-Female |
8.448400E-01 |
| Male-vs-Female |
4.838500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.719600E-02 |
| Normal-vs-Extreme_Weight |
1.075130E-03 |
| Normal-vs-Obese |
9.639800E-02 |
| Normal-vs-Extreme_Obese |
3.414800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.425400E-01 |
| Normal_Weight-vs-Obese |
4.414000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.525000E-01 |
| Extreme_Weight-vs-Obese |
1.536990E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.484800E-01 |
| Obese-vs-Extreme_Obese |
8.995800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.731800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.485700E-02 |
| Normal-vs-Age(61-80Yrs) |
7.321800E-03 |
| Normal-vs-Age(81-100Yrs) |
1.298330E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.025600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.876200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.700600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.044800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.362800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.972800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.138400E-02 |
| Normal-VS-Type2 PRCC |
9.976400E-03 |
| Normal-VS-KIRP CIMP |
3.166800E-01 |
| Normal-VS-Unclassified PRCC |
6.790800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.878000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.649400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.186600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.081600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.397250E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.190800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.11369999999489E-05 |
| Normal-vs-N1 |
4.694600E-01 |
| Normal-vs-N2 |
3.377900E-02 |
| N0-vs-N1 |
1.144200E-01 |
| N0-vs-N2 |
9.697000E-01 |
| N1-vs-N2 |
4.822600E-01 |
|
|
